Venture Life has announced the completion of the sale of its oral care brands, UltraDEX and Dentyl, including 100% of the issued share capital of Periproducts Ltd, having indicated these non-core brands were up for sale in June 2025. The company will receive £3.75m upon completion with the final consideration worth up to £4.5m, subject to customary working capital adjustments and the achievement of financial targets. We believe the disposal multiple achieved, based on FY24 performance of the ora ....
